Right ventricular myocardial infarction resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 49: Line 49:
<br><br>
<br><br>
{{familytree/end}}
{{familytree/end}}
{{Family tree/start}}
{{familytree | A01 | A01= <div style="float: left; text-align: left; width: 35em; padding:1em;"> '''Consider right ventricular MI in case of:'''
❑ [[Hypotension]]<br>
❑ Elevated [[jugular venous pressure]]<br>
❑ Clear lung fields<br>
❑ [[ECG]] changes suggestive of an [[inferior MI]] <br>
:❑ ST elevation in leads [[Echocardiogram#Limb Leads|II]], [[Echocardiogram#Limb Leads|III]] and [[Echocardiogram#Limb Leads|aVF]] </div>}}
{{familytree | |!| | }}
{{familytree | B01 | B01= <div style="float: left; text-align: left; width: 35em; padding:1em;">'''Order a right sided ECG in all patients with ST elevation in leads [[II]], [[III]] and [[aVF]]''' <br>
❑ Clearly label the [[ECG]] as right sided to minimize confusion in the emergency room and cath lab<br>
❑ ST-segment elevation of >1 mm in lead V4R suggests a right ventricular [[MI]]</div>}}
{{familytree | |!| | }}
{{familytree | C01 | C01=<div style="float: left; text-align: left; width: 35em; padding:1em;">
❑ Do not delay the decision and initiation of [[PCI]] vs [[fibrinolytic therapy]]<br>
❑ Do not administer:
:❑ [[Beta blockers]]
:❑ [[Nitrates]]
:❑ [[Diuretics]]
❑ Increase the [[right ventricle]] load by volume expansion with [[normal saline]] preferably with invasive monitoring
:❑ If central hemodynamic monitoring is available, administer normal saline (40 ml/min, up to a total of 2 L, intravenously) until there is an increase in the pulmonary capillary wedge pressure to approximately 15 mmHg <ref name="pmid24222834">{{cite journal| author=Inohara T, Kohsaka S, Fukuda K, Menon V| title=The challenges in the management of right ventricular infarction. | journal=Eur Heart J Acute Cardiovasc Care | year= 2013 | volume= 2 | issue= 3 | pages= 226-34 | pmid=24222834 | doi=10.1177/2048872613490122 | pmc=PMC3821821 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24222834  }} </ref>
:❑ If central hemodynamic monitoring in not available, administer normal saline with a close monitoring of the blood pressure </div>}}
{{familytree | |!| | }}
{{familytree | D01 | D01= <div style="float: left; text-align: left; width: 35em; padding:1em;"> '''If hypotension is not corrected with 1-2 L normal saline:'''
❑ Administer inotropic agents
: ❑&nbsp;&nbsp;[[Norepinephrine|<span style="color: #000000;">Norepinephrine</span>]]
:: ❑&nbsp;&nbsp;Initial dose: 0.5–1.0 μg/min
:: ❑&nbsp;&nbsp;Maximum dose: 30–40 μg/min
:: ❑&nbsp;&nbsp;Titrate to [[SBP|<span style="color: #000000;">SBP</span>]] &gt;90 mm Hg
: ❑&nbsp;&nbsp;[[Dopamine|<span style="color: #000000;">Dopamine</span>]]
:: ❑&nbsp;&nbsp;Cardiac dose: 5.0–10 μg/kg/min
:: ❑&nbsp;&nbsp;Pressor dose: 10–20 μg/kg/min
:: ❑&nbsp;&nbsp;Maximum dose: 20–50 μg/kg/min
: ❑&nbsp;&nbsp;[[Dobutamine|<span style="color: #000000;">Dobutamine</span>]]
:: ❑&nbsp;&nbsp;Usual dose: 2.0–20 μg/kg/min
:: ❑&nbsp;&nbsp;Maximum dose: 40 μg/kg/min
:: ❑&nbsp;&nbsp;Avoid ↑ HR by >10% of baseline
: ❑&nbsp;&nbsp;[[Milrinone|<span style="color: #000000;">Milrinone</span>]]
:: ❑&nbsp;&nbsp;Loading dose: 50 μg/kg (slowly over 10 minutes)
:: ❑&nbsp;&nbsp;Maintenance dose: 0.375–0.75 μg/kg/min
❑ Initiate hemodynamic monitoring with a [[pulmonary catheter]] if possible
</div>}}
{{Familytree/end}}


==Do's==
==Do's==

Revision as of 16:09, 4 August 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

RV infarction is a form of ST elevation myocardial infarction (STEMI) and is characterized by the presence of symptoms of myocardial ischemia associated with persistent ST elevation on electrocardiogram in right sided lead V4, and elevated cardiac enzymes, hypotension, signs of elevated right heart filling pressures (elevated neck veins) in the absence of signs of elevated left heart filling pressures (clear lung fields). Nitrates, diuretics and beta-blockers should not be administered to the patient with an RV MI.

Causes

Life Threatening Causes

STEMI is a life-threatening condition and must be treated as such irrespective of the underlying cause.

Common Causes

Management



 
 
 
 
 
 
 
 
 
 
 
 
Therapuetic Considerations in Right Ventriculay Myocardial Infarction (RVMI)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maintenance of RV preload
 
 
Decreasing RV afterload
 
Restoring Rate/Rhythm and AV synchrony
 
Inotropic support
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Avoidance of preload-reducing agents, such as:
Nitrates
Diuretics
Morphin

In patients with hypotension (without pulmonary congestion):

❑ Intravenous administration of Fluids (N/S 0.9% at 40mL/min for 1-2L, to maintain CVP <15 mmHg and PCWP between 18-24 mmHg)
 
 
Systemic or pulmonary vasodilators:
Nitrosrusside
❑ Inhaled nitric oxide
 
In patients with bradyarrhthmias:
Atropine
Pacemaker

In patients with atrioventricular block:

❑ Temporary dual-chamber pacemaker
 
In patients with refractory hypotension:
Dobutamine (along with fluids)
❑ Other inotropes:
 
 
May be needed in patients with cardiogenic shock secondary to RVMI:
❑ Direct RV support
❑ Indirect RV support
❑ Biventricular support

Do's

Don'ts

References


Template:WikiDoc Sources